{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:16:30Z","timestamp":1791486990053,"version":"4.3.4"},"reference-count":113,"publisher":"China Science Publishing & Media Ltd.","issue":"8","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.3724\/abbs.2024136","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T04:52:29Z","timestamp":1725339149000},"page":"1208-1220","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":28,"title":["Glycosylation in aging and neurodegenerative diseases"],"prefix":"10.3724","volume":"56","author":[{"given":"Weilong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"111418","DOI":"10.1016\/j.mad.2020.111418","volume":"194","author":"Ukraintseva S","year":"2021","unstructured":"Ukraintseva S, Arbeev K, Duan M, Akushevich I, Kulminski A, Stallard E, Yashin A. Decline in biological resilience as key manifestation of aging: potential mechanisms and role in health and longevity. Mech Ageing Dev, 2021, 194:","journal-title":"Mech Ageing Dev"},{"key":"CITATION2","doi-asserted-by":"crossref","unstructured":"Cindri\u0107 A, Kri\u0161ti\u0107 J, Martini\u0107 Kavur M, Pezer M. Glycosylation and aging. Adv Exp Med Biol 2021: 341-373.","DOI":"10.1007\/978-3-030-70115-4_17"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/nu8060338","volume":"8","author":"Wagner K-H","year":"2016","unstructured":"Wagner K-H, Cameron-Smith D, Wessner B, Franzke B. Biomarkers of aging: from function to molecular biology. Nutrients, 2016, 8:","journal-title":"Nutrients"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.disamonth.2015.09.005","volume":"61","author":"Lipsky MS","year":"2015","unstructured":"Lipsky MS, King M. Biological theories of aging. Dis Mon, 2015, 61: 460-466.","journal-title":"Dis Mon"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/cells8111446","volume":"8","author":"Schmeer C","year":"2019","unstructured":"Schmeer C, Kretz A, Wengerodt D, Stojiljkovic M, Witte OW. Dissecting aging and senescence-current concepts and open lessons. Cells, 2019, 8:","journal-title":"Cells"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.arr.2018.11.008","volume":"49","author":"Galkin F","year":"2019","unstructured":"Galkin F, Zhang B, Dmitriev SE, Gladyshev VN. Reversibility of irreversible aging. Ageing Res Rev, 2019, 49: 104-114.","journal-title":"Ageing Res Rev"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"L\u00f3pez-Ot\u00edn C","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell, 2023, 186: 243-278.","journal-title":"Cell"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1016\/j.cub.2019.01.003","volume":"29","author":"Eichler J","year":"2019","unstructured":"Eichler J. Protein glycosylation. Curr Biol, 2019, 29: R229-R231.","journal-title":"Curr Biol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/glycob\/cwy023","volume":"28","author":"Pearce OM","year":"2018","unstructured":"Pearce OM. Cancer glycan epitopes: biosynthesis, structure and function. Glycobiology, 2018, 28: 670-696.","journal-title":"Glycobiology"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"Varki A","year":"2017","unstructured":"Varki A. Biological roles of glycans. Glycobiology, 2017, 27: 3-49.","journal-title":"Glycobiology"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0968-0004(85)90238-5","volume":"10","author":"Olden K","year":"1985","unstructured":"Olden K, Bernard BA, Humphries MJ, Yeo T-K, Yeo K-T, White SL, Newton SA. Function of glycoprotein glycans. Trends Biochem Sci, 1985, 10: 78-82.","journal-title":"Trends Biochem Sci"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"151186","DOI":"10.1016\/j.ejcb.2021.151186","volume":"100","author":"Esmail S","year":"2021","unstructured":"Esmail S, Manolson MF. Advances in understanding N-glycosylation structure, function, and regulation in health and disease. Eur J Cell Biol, 2021, 100:","journal-title":"Eur J Cell Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","volume":"333","author":"Gudelj I","year":"2018","unstructured":"Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol, 2018, 333: 65-79.","journal-title":"Cell Immunol"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/glycob\/cwq051","volume":"20","author":"Kne\u017eevi\u0107 A","year":"2010","unstructured":"Kne\u017eevi\u0107 A, Gornik O, Pola\u0161ek O, Pu\u010di\u0107 M, Red\u017ei\u0107 I, Novokmet M, Rudd PM. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology, 2010, 20: 959-969.","journal-title":"Glycobiology"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.3390\/ijms22115788","volume":"22","author":"Paton B","year":"2021","unstructured":"Paton B, Suarez M, Herrero P, Canela N. Glycosylation biomarkers associated with age-related diseases and current methods for glycan analysis. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.3390\/molecules27248859","volume":"27","author":"Chen B","year":"2022","unstructured":"Chen B, Liu W, Li Y, Ma B, Shang S, Tan Z. Impact of N-linked glycosylation on therapeutic proteins. Molecules, 2022, 27:","journal-title":"Molecules"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.bbamcr.2013.04.001","volume":"1833","author":"Aebi M","year":"2013","unstructured":"Aebi M. N-linked protein glycosylation in the ER. Biochim Biophys Acta, 2013, 1833: 2430-2437.","journal-title":"Biochim Biophys Acta"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceb.2016.03.021","volume":"41","author":"Cherepanova N","year":"2016","unstructured":"Cherepanova N, Shrimal S, Gilmore R. N-linked glycosylation and homeostasis of the endoplasmic reticulum. Curr Opin Cell Biol, 2016, 41: 57-65.","journal-title":"Curr Opin Cell Biol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.sbi.2011.08.005","volume":"21","author":"Schwarz F","year":"2011","unstructured":"Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol, 2011, 21: 576-582.","journal-title":"Curr Opin Struct Biol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"e2216796120","DOI":"10.1073\/pnas.2216796120","volume":"120","author":"Zhu Q","year":"2023","unstructured":"Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, Wu L. O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci USA, 2023, 120:","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"BSR20220094","DOI":"10.1042\/BSR20220094","volume":"42","author":"Thompson N","year":"2022","unstructured":"Thompson N, Wakarchuk W. O-glycosylation and its role in therapeutic proteins. Biosci Rep, 2022, 42:","journal-title":"Biosci Rep"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1021\/acs.biochem.6b01244","volume":"56","author":"Mulagapati S","year":"2017","unstructured":"Mulagapati S, Koppolu V, Raju TS. Decoding of O-linked glycosylation by mass spectrometry. Biochemistry, 2017, 56: 1218-1226.","journal-title":"Biochemistry"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"12086","DOI":"10.1002\/chem.202000155","volume":"26","author":"Estevez A","year":"2020","unstructured":"Estevez A, Zhu D, Blankenship C, Jiang J. Molecular interrogation to crack the case of O-GlcNAc. Chemistry, 2020, 26: 12086-12100.","journal-title":"Chemistry"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.diabet.2010.09.001","volume":"36","author":"Issad T","year":"2010","unstructured":"Issad T, Masson E, Pagesy P. O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab, 2010, 36: 423-435.","journal-title":"Diabetes Metab"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nchembio.68","volume":"4","author":"Rexach JE","year":"2008","unstructured":"Rexach JE, Clark PM, Hsieh-Wilson LC. Chemical approaches to understanding O-GlcNAc glycosylation in the brain. Nat Chem Biol, 2008, 4: 97-106.","journal-title":"Nat Chem Biol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"9316","DOI":"10.1074\/jbc.272.14.9316","volume":"272","author":"Lubas WA","year":"1997","unstructured":"Lubas WA, Frank DW, Krause M, Hanover JA. O-linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem, 1997, 272: 9316-9324.","journal-title":"J Biol Chem"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.1074\/jbc.272.14.9308","volume":"272","author":"Kreppel LK","year":"1997","unstructured":"Kreppel LK, Blomberg MA, Hart GW. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem, 1997, 272: 9308-9315.","journal-title":"J Biol Chem"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"19321","DOI":"10.1016\/S0021-9258(17)32170-1","volume":"269","author":"Dong DL","year":"1994","unstructured":"Dong DL, Hart GW. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem, 1994, 269: 19321-19330.","journal-title":"J Biol Chem"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","volume":"53","author":"Lee BE","year":"2021","unstructured":"Lee BE, Suh PG, Kim JI. O-GlcNAcylation in health and neurodegenerative diseases. Exp Mol Med, 2021, 53: 1674-1682.","journal-title":"Exp Mol Med"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1631\/jzus.B1900150","volume":"20","author":"Nie H","year":"2019","unstructured":"Nie H, Yi W. O-GlcNAcylation, a sweet link to the pathology of diseases. J Zhejiang Univ Sci B, 2019, 20: 437-448.","journal-title":"J Zhejiang Univ Sci B"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"10451","DOI":"10.1039\/D0CS01275K","volume":"50","author":"Saha A","year":"2021","unstructured":"Saha A, Bello D, Fern\u00e1ndez-Tejada A. Advances in chemical probing of protein O-GlcNAc glycosylation: structural role and molecular mechanisms. Chem Soc Rev, 2021, 50: 10451-10485.","journal-title":"Chem Soc Rev"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1753-4887.1975.tb05227.x","volume":"33","author":"McCay CM","year":"1975","unstructured":"McCay CM, Maynard LA, Sperling G, Barnes LL. The Journal of Nutrition. Volume 18 July--December, 1939. Pages 1--13. Retarded growth, life span, ultimate body size and age changes in the albino rat after feeding diets restricted in calories. Nutr Rev, 1975, 33: 241-243.","journal-title":"Nutr Rev"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","volume":"126","author":"Ohtsubo K","year":"2006","unstructured":"Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell, 2006, 126: 855-867.","journal-title":"Cell"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/dgd.12643","volume":"62","author":"Urata Y","year":"2020","unstructured":"Urata Y, Takeuchi H. Effects of notch glycosylation on health and diseases. Dev Growth Differ, 2020, 62: 35-48.","journal-title":"Dev Growth Differ"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"751637","DOI":"10.3389\/fmolb.2021.751637","volume":"8","author":"Loaeza-Reyes KJ","year":"2021","unstructured":"Loaeza-Reyes KJ, Zenteno E, Moreno-Rodr\u00edguez A, Torres-Rosas R, Argueta-Figueroa L, Salinas-Mar\u00edn R, Castillo-Real LM. An overview of glycosylation and its impact on cardiovascular health and disease. Front Mol Biosci, 2021, 8:","journal-title":"Front Mol Biosci"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"e1001256","DOI":"10.1371\/journal.pgen.1001256","volume":"6","author":"Lauc G","year":"2010","unstructured":"Lauc G, Essafi A, Huffman JE, Hayward C, Kne\u017eevi\u0107 A, Kattla JJ, Pola\u0161ek O. Genomics meets glycomics-the first GWAS study of human N-glycome identifies HNF1\u03b1 as a master regulator of plasma protein fucosylation. PLoS Genet, 2010, 6:","journal-title":"PLoS Genet"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1093\/hmg\/ddr414","volume":"20","author":"Huffman JE","year":"2011","unstructured":"Huffman JE, Kne\u017eevi\u0107 A, Vitart V, Kattla J, Adamczyk B, Novokmet M, Igl W. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum Mol Genet, 2011, 20: 5000-5011.","journal-title":"Hum Mol Genet"},{"key":"CITATION38","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz054","author":"Sharapov SZ","year":"2019","unstructured":"Sharapov SZ, Tsepilov YA, Klaric L, Mangino M, Thareja G, Shadrina AS, Simurina M. Defining the genetic control of human blood plasma N-glycome using genome-wide association study. Hum Mol Genet, 2019,","journal-title":"Hum Mol Genet"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/glycob\/cwaa053","volume":"31","author":"Sharapov SZ","year":"2021","unstructured":"Sharapov SZ, Shadrina AS, Tsepilov YA, Elgaeva EE, Tiys ES, Feoktistova SG, Zaytseva OO. Replication of 15 loci involved in human plasma protein N-glycosylation in 4802 samples from four cohorts. Glycobiology, 2021, 31: 82-88.","journal-title":"Glycobiology"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"14509","DOI":"10.18632\/aging.205106","volume":"15","author":"Frkatovi\u0107-Hod\u017ei\u0107 A","year":"2023","unstructured":"Frkatovi\u0107-Hod\u017ei\u0107 A, Mijakovac A, Mi\u0161kec K, Nostaeva A, Sharapov SZ, Landini A, Haller T. Mapping of the gene network that regulates glycan clock of ageing. Aging, 2023, 15: 14509-14552.","journal-title":"Aging"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/molecules29061281","volume":"29","author":"Sun W","year":"2024","unstructured":"Sun W, Jian X, Zhang J, Meng X, Wang H, Zheng D, Wu L. The causality between human immunoglobulin G (IgG) N-glycosylation and aging: a mendelian randomization study. Molecules, 2024, 29:","journal-title":"Molecules"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/biomedicines10081805","volume":"10","author":"Sobral D","year":"2022","unstructured":"Sobral D, Francisco R, Duro L, Videira PA, Grosso AR. Concerted regulation of glycosylation factors sustains tissue identity and function. Biomedicines, 2022, 10:","journal-title":"Biomedicines"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"982609","DOI":"10.3389\/fcell.2022.982609","volume":"10","author":"Mijakovac A","year":"2022","unstructured":"Mijakovac A, Frkatovi\u0107 A, Hani\u0107 M, Ivok J, Martini\u0107 Kavur M, Pu\u010di\u0107-Bakovi\u0107 M, Spector T. Heritability of the glycan clock of biological age. Front Cell Dev Biol, 2022, 10:","journal-title":"Front Cell Dev Biol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41366-021-00816-3","volume":"45","author":"Greto VL","year":"2021","unstructured":"Greto VL, Cvetko A, \u0160tambuk T, Dempster NJ, Kifer D, Deri\u0161 H, Cindri\u0107 A. Extensive weight loss reduces glycan age by altering IgG N-glycosylation. Int J Obes, 2021, 45: 1521-1531.","journal-title":"Int J Obes"},{"key":"CITATION45","doi-asserted-by":"crossref","unstructured":"\u0160imuni\u0107-Bri\u0161ki N, Dukari\u0107 V, O\u010di\u0107 M, Mad\u017ear T, Vinicki M, Frkatovi\u0107-Hod\u017ei\u0107 A, Knjaz D, et al. Regular moderate physical exercise decreases glycan age index of biological age and reduces inflammatory potential of Immunoglobulin G. Glycoconj J 2024, 41: 67\u201376.","DOI":"10.1007\/s10719-023-10144-5"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"e13855","DOI":"10.1111\/acel.13855","volume":"22","author":"Fan J","year":"2023","unstructured":"Fan J, Sha J, Chang S, Zhao H, Niu X, Gu Y, Gu J. Generalized low levels of serum N-glycans associate with better health status. Aging Cell, 2023, 22:","journal-title":"Aging Cell"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"G667","DOI":"10.1152\/ajpgi.00199.2010","volume":"301","author":"Burger-van Paassen N","year":"2011","unstructured":"Burger-van Paassen N, van der Sluis M, Bouma J, Korteland-van Male AM, Lu P, Van Seuningen I, Boehm G. Colitis development during the suckling-weaning transition in mucin Muc2-deficient mice. Am J Physiol Gastrointest Liver Physiol, 2011, 301: G667-G678.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/nu15081830","volume":"15","author":"Sang X","year":"2023","unstructured":"Sang X, Wang Q, Ning Y, Wang H, Zhang R, Li Y, Fang B. Age-related mucus barrier dysfunction in mice is related to the changes in muc2 mucin in the colon. Nutrients, 2023, 15:","journal-title":"Nutrients"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"104967","DOI":"10.1016\/j.archoralbio.2020.104967","volume":"121","author":"Kameyama A","year":"2021","unstructured":"Kameyama A, Thet Tin WW, Nishijima R, Yamakoshi K. Alteration of mucins in the submandibular gland during aging in mice. Arch Oral Biol, 2021, 121:","journal-title":"Arch Oral Biol"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"mjac016","DOI":"10.1093\/jmcb\/mjac016","volume":"14","author":"Wu J","year":"2022","unstructured":"Wu J, Liu J, Lapenta K, Desrouleaux R, Li MD, Yang X, Liu F. Regulation of the urea cycle by CPS1 O-GlcNAcylation in response to dietary restriction and aging. J Mol Cell Biol, 2022, 14:","journal-title":"J Mol Cell Biol"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"111451","DOI":"10.1016\/j.celrep.2022.111451","volume":"41","author":"Liu B","year":"2022","unstructured":"Liu B, Qu J, Zhang W, Izpisua Belmonte JC, Liu GH. A stem cell aging framework, from mechanisms to interventions. Cell Rep, 2022, 41:","journal-title":"Cell Rep"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"102877","DOI":"10.1016\/j.redox.2023.102877","volume":"67","author":"Zhou Z","year":"2023","unstructured":"Zhou Z, Zhang H, Tao Y, Zang J, Zhao J, Li H, Wang Y. FGF21 alleviates adipose stem cell senescence via CD90 glycosylation-dependent glucose influx in remodeling healthy white adipose tissue. Redox Biol, 2023, 67:","journal-title":"Redox Biol"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"114770","DOI":"10.1016\/j.ab.2022.114770","volume":"652","author":"Wang J","year":"2022","unstructured":"Wang J, Zhao K, Chen L, Zhou J, Sun Q, Chen J, Su R. Proteomics and post-translational modifications analysis of umbilical mesenchymal stem cells aging. Anal Biochem, 2022, 652:","journal-title":"Anal Biochem"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"cwae032","DOI":"10.1093\/glycob\/cwae032","volume":"34","author":"Imae R","year":"2024","unstructured":"Imae R, Manya H, Tsumoto H, Umezawa K, Miura Y, Endo T. Changes in the amount of nucleotide sugars in aged mouse tissues. Glycobiology, 2024, 34:","journal-title":"Glycobiology"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1096\/fba.2023-00011","volume":"5","author":"G\u00fcnay B","year":"2023","unstructured":"G\u00fcnay B, Matthews E, Morgan J, Tryfonidou MA, Saldova R, Pandit A. An insight on the N-glycome of notochordal cell-rich porcine nucleus pulposus during maturation. FASEB BioAdv, 2023, 5: 321-335.","journal-title":"FASEB BioAdv"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"111971","DOI":"10.1016\/j.mce.2023.111971","volume":"574","author":"McDonald R","year":"2023","unstructured":"McDonald R, Larsen M, Liu Z, Southekal S, Eudy J, Guda C, Kumar TR. RNA-seq analysis identifies age-dependent changes in expression of mRNAs encoding N-glycosylation pathway enzymes in mouse gonadotropes. Mol Cell Endocrinol, 2023, 574:","journal-title":"Mol Cell Endocrinol"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/labmed\/lmaa062","volume":"52","author":"Agnello L","year":"2021","unstructured":"Agnello L, Gambino CM, Lo Sasso B, Bivona G, Milano S, Ciaccio AM, Piccoli T. Neurogranin as a novel biomarker in Alzheimer\u2019s disease. Lab Med, 2021, 52: 188-196.","journal-title":"Lab Med"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.3390\/ijms22168654","volume":"22","author":"Cheng YJ","year":"2021","unstructured":"Cheng YJ, Lin CH, Lane HY. From menopause to neurodegeneration\u2014molecular basis and potential therapy. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40035-017-0096-2","volume":"6","author":"Cummings J","year":"2017","unstructured":"Cummings J. Disease modification and neuroprotection in neurodegenerative disorders. Transl Neurodegener, 2017, 6:","journal-title":"Transl Neurodegener"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1242\/dmm.030205","volume":"10","author":"Gitler AD","year":"2017","unstructured":"Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech, 2017, 10: 499-502.","journal-title":"Dis Model Mech"},{"key":"CITATION61","unstructured":"Katsuno M, Sahashi K, Iguchi Y, Hashizume A. Preclinical progression of neurodegenerative diseases. Nagoya J Med Sci 2018, 80: 289\u2013298."},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"Guo J","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, Li J. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther, 2022, 7:","journal-title":"Signal Transduct Target Ther"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"e158453","DOI":"10.1172\/JCI158453","volume":"132","author":"Gonzales MM","year":"2022","unstructured":"Gonzales MM, Garbarino VR, Pollet E, Palavicini JP, Kellogg Jr. DL, Kraig E, Orr ME. Biological aging processes underlying cognitive decline and neurodegenerative disease. J Clin Invest, 2022, 132:","journal-title":"J Clin Invest"},{"key":"CITATION64","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00168","volume":"7: 168","author":"Johnson IP","year":"2015","unstructured":"Johnson IP. Age-related neurodegenerative disease research needs aging models. Front Aging Neurosci, 2015, 7: 168:","journal-title":"Front Aging Neurosci"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"101991","DOI":"10.1016\/j.arr.2023.101991","volume":"89","author":"Costa J","year":"2023","unstructured":"Costa J, Hayes C, Lisacek F. Protein glycosylation and glycoinformatics for novel biomarker discovery in neurodegenerative diseases. Ageing Res Rev, 2023, 89:","journal-title":"Ageing Res Rev"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"e202300017","DOI":"10.1002\/cbic.202300017","volume":"24","author":"Yang J","year":"2023","unstructured":"Yang J, Li H, Zhao Y. Dessert or poison? The roles of glycosylation in Alzheimer's, Parkinson's, Huntington's disease, and amyotrophic lateral sclerosis. ChemBioChem, 2023, 24:","journal-title":"ChemBioChem"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"Grad LI","year":"2017","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med, 2017, 7:","journal-title":"Cold Spring Harb Perspect Med"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"Hardiman O","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ. Amyotrophic lateral sclerosis. Nat Rev Dis Primers, 2017, 3: 1-9.","journal-title":"Nat Rev Dis Primers"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"e35772","DOI":"10.1371\/journal.pone.0035772","volume":"7","author":"Edri-Brami M","year":"2012","unstructured":"Edri-Brami M, Rosental B, Hayoun D, Welt M, Rosen H, Wirguin I, Nefussy B. Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells. PLoS One, 2012, 7:","journal-title":"PLoS One"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cca.2014.09.011","volume":"438","author":"Goncalves M","year":"2015","unstructured":"Goncalves M, Tillack L, de Carvalho M, Pinto S, Conradt HS, Costa J. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clinica Chim Acta, 2015, 438: 342-349.","journal-title":"Clinica Chim Acta"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1007\/s12035-019-1482-9","volume":"56","author":"Costa J","year":"2019","unstructured":"Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M. Exploring cerebrospinal fluid IgG N-glycosylation as potential biomarker for amyotrophic lateral sclerosis. Mol Neurobiol, 2019, 56: 5729-5739.","journal-title":"Mol Neurobiol"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/srep00573","volume":"2","author":"Tanaka H","year":"2012","unstructured":"Tanaka H, Shimazawa M, Kimura M, Takata M, Tsuruma K, Yamada M, Takahashi H. The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep, 2012, 2:","journal-title":"Sci Rep"},{"key":"CITATION73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neulet.2012.04.018","volume":"516","author":"Shan X","year":"2012","unstructured":"Shan X, Vocadlo DJ, Krieger C. Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett, 2012, 516: 296-301.","journal-title":"Neurosci Lett"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"Hayes MT","year":"2019","unstructured":"Hayes MT. Parkinson\u2032s disease and parkinsonism. Am J Med, 2019, 132: 802-807.","journal-title":"Am J Med"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/glycob\/cwx022","volume":"27","author":"Russell AC","year":"2017","unstructured":"Russell AC, \u0160imurina M, Garcia MT, Novokmet M, Wang Y, Rudan I, Campbell H. The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson\u2032s disease. Glycobiology, 2017, 27: 501-510.","journal-title":"Glycobiology"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/molecules24122220","volume":"24","author":"V\u00e1radi C","year":"2019","unstructured":"V\u00e1radi C, Neh\u00e9z K, Horny\u00e1k O, Viskolcz B, Bones J. Serum N-glycosylation in parkinson\u2019s disease: a novel approach for potential alterations. Molecules, 2019, 24:","journal-title":"Molecules"},{"key":"CITATION77","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1021\/acs.jproteome.1c00219","volume":"20","author":"Wilkinson H","year":"2021","unstructured":"Wilkinson H, Thomsson KA, Rebelo AL, Hilliard M, Pandit A, Rudd PM, Karlsson NG. The O-glycome of human nigrostriatal tissue and Its alteration in parkinson\u2019s disease. J Proteome Res, 2021, 20: 3913-3924.","journal-title":"J Proteome Res"},{"key":"CITATION78","doi-asserted-by":"publisher","first-page":"pgad439","DOI":"10.1093\/pnasnexus\/pgad439","volume":"3","author":"Rebelo AL","year":"2024","unstructured":"Rebelo AL, Drake RR, Marchetti-Deschmann M, Saldova R, Pandit A. Changes in tissue protein N-glycosylation and associated molecular signature occur in the human Parkinsonian brain in a region-specific manner. PNAS Nexus, 2024, 3:","journal-title":"PNAS Nexus"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1038\/s41467-024-46898-1","volume":"15","author":"Hu J","year":"2024","unstructured":"Hu J, Xia W, Zeng S, Lim YJ, Tao Y, Sun Y, Zhao L. Phosphorylation and O-glcNAcylation at the same \u03b1-synuclein site generate distinct fibril structures. Nat Commun, 2024, 15:","journal-title":"Nat Commun"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1021\/acschemneuro.2c00264","volume":"13","author":"Xu M","year":"2022","unstructured":"Xu M, Jin H, Wu Z, Han Y, Chen J, Mao C, Hao P. Mass spectrometry-based analysis of serum N-glycosylation changes in patients with parkinson\u2019s disease. ACS Chem Neurosci, 2022, 13: 1719-1726.","journal-title":"ACS Chem Neurosci"},{"key":"CITATION81","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1021\/acschemneuro.3c00404","volume":"14","author":"Xu M","year":"2023","unstructured":"Xu M, Jin H, Ge W, Zhao L, Liu Z, Guo Z, Wu Z. Mass spectrometric analysis of urinary N-glycosylation changes in patients with parkinson\u2019s disease. ACS Chem Neurosci, 2023, 14: 3507-3517.","journal-title":"ACS Chem Neurosci"},{"key":"CITATION82","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/cells8121588","volume":"8","author":"Winter J","year":"2019","unstructured":"Winter J, Hammer E, Heger J, Schultheiss HP, Rauch U, Landmesser U, D\u00f6rner A. Adenine nucleotide translocase 1 expression is coupled to the HSP27-mediated TLR4 signaling in cardiomyocytes. Cells, 2019, 8:","journal-title":"Cells"},{"key":"CITATION83","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s11064-022-03688-9","volume":"47","author":"Zhang W","year":"2022","unstructured":"Zhang W, Liu J, Chen Q, Ding W, Li S, Ma L. Identification of ADP\/ATP translocase 1 as a novel glycoprotein and its association with parkinson\u2019s disease. Neurochem Res, 2022, 47: 3355-3368.","journal-title":"Neurochem Res"},{"key":"CITATION84","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.18632\/aging.102072","volume":"11","author":"Ma L","year":"2019","unstructured":"Ma L, Song J, Sun X, Ding W, Fan K, Qi M, Xu Y. Role of microtubule-associated protein 6 glycosylated with Gal-(\u03b2-1,3)-GalNAc in Parkinson\u2032s disease. Aging, 2019, 11: 4597-4610.","journal-title":"Aging"},{"key":"CITATION85","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"Scheltens P","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J. Alzheimer's disease. Lancet, 2021, 397: 1577-1590.","journal-title":"Lancet"},{"key":"CITATION86","doi-asserted-by":"crossref","unstructured":"Knapskog AB, Engedal K, Selb\u00e6k G, \u00d8kseng\u00e5rd AR. Alzheimers sykdom\u2013diagnostikk og behandling. Tidsskr Nor Laegeforen 2021, 141.","DOI":"10.4045\/tidsskr.20.0919"},{"key":"CITATION87","doi-asserted-by":"crossref","unstructured":"Soria Lopez JA, Gonz\u00e1lez HM, L\u00e9ger GC. Alzheimer's disease. Handb Clin Neurol 2019, 167: 231-255.","DOI":"10.1016\/B978-0-12-804766-8.00013-3"},{"key":"CITATION88","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.14506.1","volume":"7","author":"Weller J","year":"2018","unstructured":"Weller J, Budson A. Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res, 2018, 7:","journal-title":"F1000Res"},{"key":"CITATION89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"O\u2032Brien RJ","year":"2011","unstructured":"O\u2032Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci, 2011, 34: 185-204.","journal-title":"Annu Rev Neurosci"},{"key":"CITATION90","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/glycob\/cwac009","volume":"32","author":"Lin T","year":"2022","unstructured":"Lin T, van Husen LS, Yu Y, Tjernberg LO, Schedin-Weiss S. Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein. Glycobiology, 2022, 32: 506-517.","journal-title":"Glycobiology"},{"key":"CITATION91","doi-asserted-by":"publisher","first-page":"104905","DOI":"10.1016\/j.jbc.2023.104905","volume":"299","author":"Tachida Y","year":"2023","unstructured":"Tachida Y, Iijima J, Takahashi K, Suzuki H, Kizuka Y, Yamaguchi Y, Tanaka K. O-GalNAc glycosylation determines intracellular trafficking of APP and A\u03b2 production. J Biol Chem, 2023, 299:","journal-title":"J Biol Chem"},{"key":"CITATION92","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1002\/alz.13124","volume":"19","author":"Kronimus Y","year":"2023","unstructured":"Kronimus Y, Albus A, Hasenberg M, Walkenfort B, Seifert M, Budeus B, Gronewold J. Fc N-glycosylation of autoreactive A\u03b2 antibodies as a blood-based biomarker for Alzheimer's disease. Alzheimers Dement, 2023, 19: 5563-5572.","journal-title":"Alzheimers Dement"},{"key":"CITATION93","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1152\/physrev.00024.2003","volume":"84","author":"Avila J","year":"2004","unstructured":"Avila J, Lucas JJ, P\u00e9rez M, Hern\u00e1ndez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev, 2004, 84: 361-384.","journal-title":"Physiol Rev"},{"key":"CITATION94","unstructured":"P\u00eer\u015fcoveanu DFV, Pirici I, Tudoric\u0103 V, B\u0103l\u015feanu TA, Albu VC, Bondari S, Bumbea AM, et al. Tau protein in neurodegenerative diseases a review. Rom J Morphol Embryol 2017, 58: 1141\u20131150."},{"key":"CITATION95","doi-asserted-by":"crossref","unstructured":"Kovacs GG. Tauopathies. Handb Clin Neurol 2017, 145: 355-368.","DOI":"10.1016\/B978-0-12-802395-2.00025-0"},{"key":"CITATION96","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3233\/JAD-2004-6505","volume":"6","author":"Robertson LA","year":"2004","unstructured":"Robertson LA, Moya KL, Breen KC. The potential role of tau protein O-glycosylation in Alzheimer's disease. J Alzheimer Dis, 2004, 6: 489-495.","journal-title":"J Alzheimer Dis"},{"key":"CITATION97","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41420-023-01617-5","volume":"9","author":"Zhao J","year":"2023","unstructured":"Zhao J, Lang M. New insight into protein glycosylation in the development of Alzheimer\u2019s disease. Cell Death Discov, 2023, 9:","journal-title":"Cell Death Discov"},{"key":"CITATION98","doi-asserted-by":"publisher","first-page":"625348","DOI":"10.3389\/fnins.2020.625348","volume":"14","author":"Haukedal H","year":"2020","unstructured":"Haukedal H, Freude KK. Implications of glycosylation in Alzheimer\u2019s disease. Front Neurosci, 2020, 14:","journal-title":"Front Neurosci"},{"key":"CITATION99","doi-asserted-by":"publisher","first-page":"661368","DOI":"10.3389\/fnmol.2021.661368","volume":"14","author":"Cantrelle FX","year":"2021","unstructured":"Cantrelle FX, Loyens A, Trivelli X, Reimann O, Despres C, Gandhi NS, Hackenberger CPR. Phosphorylation and O-GlcNAcylation of the PHF-1 epitope of tau protein induce local conformational changes of the C-terminus and modulate tau self-assembly into fibrillar aggregates. Front Mol Neurosci, 2021, 14:","journal-title":"Front Mol Neurosci"},{"key":"CITATION100","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1038\/s41380-022-01689-2","volume":"27","author":"Yin X","year":"2022","unstructured":"Yin X, Li Y, Fan X, Huang F, Qiu Y, Zhao C, Zhou Z. SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy. Mol Psychiatry, 2022, 27: 4323-4334.","journal-title":"Mol Psychiatry"},{"key":"CITATION101","doi-asserted-by":"publisher","first-page":"135","DOI":"10.31083\/j.jin2205135","volume":"22","author":"Rostgaard N","year":"2023","unstructured":"Rostgaard N, Jul PH, Garmer M, Volbracht C. Increasing O-GlcNAcylation attenuates tau hyperphosphorylation and behavioral impairment in rTg4510 tauopathy mice. J Integr Neurosci, 2023, 22:","journal-title":"J Integr Neurosci"},{"key":"CITATION102","doi-asserted-by":"publisher","first-page":"eabd3207","DOI":"10.1126\/sciadv.abd3207","volume":"7","author":"Park J","year":"2021","unstructured":"Park J, Ha HJ, Chung ES, Baek SH, Cho Y, Kim HK, Han J. O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer\u2019s disease by inhibiting necroptosis. Sci Adv, 2021, 7:","journal-title":"Sci Adv"},{"key":"CITATION103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-201450","volume":"81","author":"Pan D","year":"2021","unstructured":"Pan D, Gu JH, Zhang J, Hu Y, Liu F, Iqbal K, Cekic N. Thiamme2-G, a novel O-GlcNAcase inhibitor, reduces tau hyperphosphorylation and rescues cognitive impairment in mice. J Alzheimer Dis, 2021, 81: 273-286.","journal-title":"J Alzheimer Dis"},{"key":"CITATION104","doi-asserted-by":"publisher","first-page":"757801","DOI":"10.3389\/fragi.2021.757801","volume":"2","author":"Huynh VN","year":"2021","unstructured":"Huynh VN, Wang S, Ouyang X, Wani WY, Johnson MS, Chacko BK, Jegga AG. Defining the dynamic regulation of O-GlcNAc proteome in the mouse cortex---the O-GlcNAcylation of synaptic and trafficking proteins related to neurodegenerative diseases. Front Aging, 2021, 2:","journal-title":"Front Aging"},{"key":"CITATION105","doi-asserted-by":"publisher","first-page":"114444","DOI":"10.1016\/j.ejmech.2022.114444","volume":"238","author":"Li X","year":"2022","unstructured":"Li X, Han J, Bujaranipalli S, He J, Kim EY, Kim H, Im JH. Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease. Eur J Med Chem, 2022, 238:","journal-title":"Eur J Med Chem"},{"key":"CITATION106","doi-asserted-by":"publisher","first-page":"765259","DOI":"10.3389\/fnagi.2021.765259","volume":"13","author":"Yu L","year":"2021","unstructured":"Yu L, Huo Z, Yang J, Palma-Gudiel H, Boyle PA, Schneider JA, Bennett DA. Human brain and blood N-glycome profiling in Alzheimer's disease and Alzheimer's disease-related dementias. Front Aging Neurosci, 2021, 13:","journal-title":"Front Aging Neurosci"},{"key":"CITATION107","doi-asserted-by":"publisher","first-page":"e12309","DOI":"10.1002\/dad2.12309","volume":"14","author":"Tena J","year":"2022","unstructured":"Tena J, Tang X, Zhou Q, Harvey D, Barajas-Mendoza M, Jin LW, Maezawa I. Glycosylation alterations in serum of Alzheimer's disease patients show widespread changes in N-glycosylation of proteins related to immune function, inflammation, and lipoprotein metabolism. Alzheimers Dement (Amst), 2022, 14:","journal-title":"Alzheimers Dement (Amst)"},{"key":"CITATION108","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.mcpro.2022.100433","volume":"21","author":"Suttapitugsakul S","year":"2022","unstructured":"Suttapitugsakul S, Stavenhagen K, Donskaya S, Bennett DA, Mealer RG, Seyfried NT, Cummings RD. Glycoproteomics landscape of asymptomatic and symptomatic human Alzheimer\u2019s disease brain. Mol Cell Proteomics, 2022, 21:","journal-title":"Mol Cell Proteomics"},{"key":"CITATION109","doi-asserted-by":"publisher","first-page":"e209223","DOI":"10.1212\/WNL.0000000000209223","volume":"102","author":"Buchman AS","year":"2024","unstructured":"Buchman AS, Yu L, Klein HU, Zammit AR, Oveisgharan S, Nag S, Tickotsky N. Glycoproteome-wide discovery of cortical glycoproteins that may provide cognitive resilience in older adults. Neurology, 2024, 102:","journal-title":"Neurology"},{"key":"CITATION110","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1002\/alz.13024","volume":"19","author":"Zhou RZ","year":"2023","unstructured":"Zhou RZ, Vetrano DL, Grande G, Duell F, J\u00f6nsson L, Laukka EJ, Fredolini C. A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status. Alzheimers Dement, 2023, 19: 3244-3249.","journal-title":"Alzheimers Dement"},{"key":"CITATION111","doi-asserted-by":"publisher","first-page":"968190","DOI":"10.3389\/fnagi.2022.968190","volume":"14","author":"Ma Z","year":"2022","unstructured":"Ma Z, Yang F, Fan J, Li X, Liu Y, Chen W, Sun H. Identification and immune characteristics of molecular subtypes related to protein glycosylation in Alzheimer\u2019s disease. Front Aging Neurosci, 2022, 14:","journal-title":"Front Aging Neurosci"},{"key":"CITATION112","doi-asserted-by":"publisher","first-page":"1120086","DOI":"10.3389\/fnins.2023.1120086","volume":"17","author":"Haukedal H","year":"2023","unstructured":"Haukedal H, Corsi GI, Gadekar VP, Doncheva NT, Kedia S, de Haan N, Chandrasekaran A. Golgi fragmentation\u2013one of the earliest organelle phenotypes in Alzheimer\u2019s disease neurons. Front Neurosci, 2023, 17:","journal-title":"Front Neurosci"},{"key":"CITATION113","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/alz.12523","volume":"18","author":"Hawkinson TR","year":"2022","unstructured":"Hawkinson TR, Clarke HA, Young LEA, Conroy LR, Markussen KH, Kerch KM, Johnson LA. In situ spatial glycomic imaging of mouse and human Alzheimer's disease brains. Alzheimers Dement, 2022, 18: 1721-1735.","journal-title":"Alzheimers Dement"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/261CD105100F4353A04A5CD60B653A67","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/261CD105100F4353A04A5CD60B653A67","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:16:13Z","timestamp":1732162573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":113,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,15]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024136","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}